Team
health

LV Mass Index Calculator

Rapid quantification of cardiac geometry from standard echo parameters. Cardiologists, sonographers, and clinical trainees use this tool to compute left ventricular mass, assess hypertrophy burden via mass index, and measure relative wall thickness—all essential for risk stratification in hypertension, aortic stenosis, and heart failure phenotyping.

Last updated:

Creators Małgorzata Koperska, MD
3,564 people find this calculator helpful

Understanding Left Ventricular Measurements

Echocardiographic assessment of left ventricular structure underpins modern cardiology. Three end-diastolic dimensions form the basis: left ventricular end-diastolic diameter (LVEDD), interventricular septal thickness (IVSd), and posterior wall thickness (PWd). From these linear measurements, we derive left ventricular mass (LVMass), expressed in grams.

Left ventricular mass index (LVMI) normalizes this mass to body surface area, yielding values in g/m². This indexation corrects for body size, allowing direct comparison across patients of different statures. Relative wall thickness (RWT) captures the relationship between wall thickness and chamber size, distinguishing concentric remodelling from eccentric hypertrophy.

  • LVMI normal ranges: women 43–95 g/m², men 49–115 g/m²
  • Moderate hypertrophy: women 109–121 g/m², men 132–148 g/m²
  • RWT >0.42 indicates concentric geometry

LV Mass and Derived Indices

The Devereux formula, standardised in major hypertension and cardiology guidelines, calculates ventricular mass from three linear dimensions. Body surface area is derived from Mosteller's equation, which correlates well with direct measurement and is more practical than nomograms.

LV Mass (g) = 0.8 × [1.04 × ((LVEDD + IVSd + PWd)³ − LVEDD³)] + 0.6

LVMI (g/m²) = LV Mass ÷ BSA

RWT = (2 × PWd) ÷ LVEDD

BSA (m²) = √[(Height × Weight) ÷ 3600]

  • LVEDD — Left ventricular end-diastolic diameter in millimetres, measured from the inner endocardium at the widest point during diastole
  • IVSd — Interventricular septal thickness at end-diastole in millimetres
  • PWd — Posterior left ventricular wall thickness at end-diastole in millimetres
  • BSA — Body surface area in square metres; calculated from height (cm) and weight (kg)
  • LV Mass — Left ventricular mass in grams, representing the total myocardial tissue
  • LVMI — Left ventricular mass indexed to body surface area, normalised in g/m²
  • RWT — Relative wall thickness, a dimensionless ratio reflecting geometry pattern

Clinical Interpretation and Hypertrophy Patterns

An elevated LVMI signals left ventricular hypertrophy (LVH), commonly seen in chronic hypertension, aortic stenosis, and restrictive cardiomyopathies. The degree of elevation predicts cardiovascular outcomes: each 50 g/m² increase in LVMI carries increased mortality risk, independent of blood pressure.

RWT further refines the phenotype. When RWT remains normal (<0.42) despite elevated mass, hypertrophy is eccentric—the chamber dilates proportionally. When RWT exceeds 0.42 with high LVMI, hypertrophy is concentric, indicating disproportionate wall thickening. Concentric patterns confer worse prognosis and are associated with diastolic dysfunction.

Serial measurement tracks response to antihypertensive therapy or surgical intervention. Regression of LVH over 6–12 months suggests disease stabilisation and improved long-term survival prospects.

Key Caveats in LV Mass Measurement

Accurate echo-derived LV mass requires meticulous technique and awareness of common pitfalls.

  1. Measurement plane and axis alignment — LVEDD, IVSd, and PWd must originate from the parasternal long-axis view at the level of the mitral valve leaflet tips. Oblique or foreshortened views systematically underestimate diameter and overestimate wall thickness. Perpendicularity to the ultrasound beam is crucial for reproducibility.
  2. Gain and compression settings — Excessive gain creates artifactual thickening of borders; too little gain causes foreshortening. Modern machines allow optimisation of compression curves. Consistent machine and transducer settings between serial studies improve trend detection.
  3. Geometric assumptions — The Devereux formula assumes a prolate ellipsoid geometry and may misestimate mass in severely dilated or remodelled ventricles. In advanced heart failure or post-infarction states, 3D echo offers superior accuracy.
  4. Body surface area input — Miscalculation or transcription errors in height and weight directly propagate to LVMI. Verify units (centimetres and kilograms) before entry. Obesity and oedema-related weight gain can spuriously inflate BSA and mask true mass elevation.

Frequently Asked Questions

What do LVEDD, IVSd, and PWd represent in an echocardiogram?

LVEDD is the internal diameter of the left ventricle at its widest point during diastole, measured in millimetres. IVSd is the thickness of the wall separating the two ventricles at end-diastole. PWd is the thickness of the posterior free wall at the same phase. Together, these three measurements define the chamber and wall geometry needed to compute ventricular mass using the Devereux formula.

Why is body surface area used to index left ventricular mass?

Larger individuals naturally have larger hearts; absolute mass correlates strongly with body size. Indexing to body surface area removes this confounding factor, allowing clinicians to compare LVMI across patients of vastly different heights and weights on a single scale. This normalisation improves risk stratification and comparability with published epidemiological reference ranges.

What is the clinical significance of relative wall thickness above 0.42?

When RWT exceeds 0.42, the left ventricle exhibits concentric geometry—wall thickness increases disproportionately relative to chamber diameter. This pattern, often seen in hypertension and aortic stenosis, is associated with impaired diastolic filling, reduced exercise tolerance, and higher cardiovascular event rates compared to eccentric hypertrophy at similar LVMI values.

Can LVMI predict heart failure risk?

Yes. LVMI is a strong independent predictor of heart failure incidence and mortality. Studies show that each 50 g/m² increment in LVMI increases heart failure risk by approximately 5–10% over 5–10 years, even after adjustment for blood pressure and other covariates. LVMI screening in hypertensive cohorts identifies high-risk individuals for intensive treatment or closer monitoring.

How often should left ventricular mass be reassessed?

In asymptomatic patients with hypertension and LVH, annual or biennial echocardiography is reasonable to track response to therapy. After initiation of antihypertensive agents, meaningful regression of LVMI typically requires 6–12 months of sustained blood pressure control. In symptomatic disease or after cardiac surgery, earlier reassessment (3–6 months) may guide management changes.

Are there limitations to the Devereux formula?

The Devereux equation assumes a prolate ellipsoid model and may systematically over- or underestimate mass in severely remodelled ventricles, such as those with apical aneurysm, post-infarction dyskinesis, or advanced dilated cardiomyopathy. In such cases, 3D echocardiography or cardiac magnetic resonance provides superior accuracy and should be considered.

health
ACFT Calculator

More health calculators (see all)

BMI for Men Calculator Cardiac Index Calculator BBT Calculator GAD-7 Calculator PSA Doubling Time Calculator Baby Percentile Calculator BMI Calculator Melatonin Dosage Calculator